West Pharmaceutical Services Aktie
WKN: 864330 / ISIN: US9553061055
|
12.02.2026 12:08:07
|
West Pharmaceutical Services Inc. Q4 Income Rises
(RTTNews) - West Pharmaceutical Services Inc. (WST) released a profit for its fourth quarter that Increases, from the same period last year
The company's bottom line came in at $132.1 million, or $1.82 per share. This compares with $130.1 million, or $1.78 per share, last year.
Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $147.8 million or $2.04 per share for the period.
The company's revenue for the period rose 7.5% to $805.0 million from $748.8 million last year.
West Pharmaceutical Services Inc. earnings at a glance (GAAP) :
-Earnings: $132.1 Mln. vs. $130.1 Mln. last year. -EPS: $1.82 vs. $1.78 last year. -Revenue: $805.0 Mln vs. $748.8 Mln last year.
-Guidance: Next quarter EPS guidance: $ 1.65 To $ 1.70 Next quarter revenue guidance: $ 770 M To $ 790 M
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu West Pharmaceutical Services Inc.
Analysen zu West Pharmaceutical Services Inc.
Aktien in diesem Artikel
| West Pharmaceutical Services Inc. | 202,70 | -3,89% |
|